The therapeutic effects of MSc1 nanocomplex, synthesized by nanochelating technology, on experimental autoimmune encephalomyelitic C57/BL6 mice
International Journal of Nanomedicine, August 2014
Mohammad Hassan Nazaran, Saideh f Fakharzadeh, Mohammad Ali Sahraian, Maryam Hafizi, Somayeh Kalanaky, Zahra Masoumi, Mehdi Mahdavi, Alireza Minagar, Nasser Kamalian
Currently approved therapies for multiple sclerosis (MS) at best only slow down its progression. Therefore, it is necessary to utilize novel technologies in order to synthesize smart multifunctional structures. In the present study, for the first time we evaluated the therapeutic potential of MSc1 nanocomplex, which was designed based on novel nanochelating technology.
|Readers by professional status||Count||As %|
|Readers by discipline||Count||As %|